BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchihara Y, Permata TBM, Sato H, Kawabata-Iwakawa R, Katada S, Gu W, Kakoti S, Yamauchi M, Kato R, Gondhowiardjo S, Hosen N, Yasuhara T, Shibata A. DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production. Mol Cell 2022:S1097-2765(22)00393-8. [PMID: 35594857 DOI: 10.1016/j.molcel.2022.04.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan C, Tang H, Wang W, Wu D, Luo H, Xu L, Lin X. An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1077477] [Reference Citation Analysis]
2 Chen B, Zhu H, Yang B, Cao J. The dichotomous role of immunoproteasome in cancer: Friend or foe? Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.005] [Reference Citation Analysis]
3 Gómez-herranz M, Dziadosz A, Mikac S, Rychłowski M, Fahraeus R, Marek-trzonkowska N, Chruściel E, Urban-wójciuk Z, Papak I, Arcimowicz Ł, Marjanski T, Rzyman W, Sznarkowska A. Major Histocompatibility Complex class I heavy chains localize in both cytoplasmic and nuclear compartment.. [DOI: 10.1101/2022.09.13.507738] [Reference Citation Analysis]